U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C60H96N20O21S2
Molecular Weight 1497.656
Optical Activity UNSPECIFIED
Defined Stereocenters 19 / 19
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of BLEOMYCIN A6

SMILES

[H][C@]6(O[C@@H]1[C@H](O[C@H]([C@H](NC(=O)C2=NC(=NC(N)=C2C)[C@H](CC(N)=O)NC[C@H](N)C(N)=O)C(=O)N[C@H](C)[C@@H](O)[C@H](C)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCCC3=NC(=CS3)C4=NC(=CS4)C(=O)NCCCNCCCCNCCCN)C5=CN=CN5)O[C@@H](CO)[C@@H](O)[C@@H]1O)O[C@H](CO)[C@@H](O)[C@H](OC(N)=O)[C@@H]6O

InChI

InChIKey=FOUFFVYWFNBHHH-YNGSZULRSA-N
InChI=1S/C60H96N20O21S2/c1-25-38(77-51(80-49(25)64)30(17-36(63)84)72-18-29(62)50(65)90)55(94)79-40(46(31-19-69-24-73-31)99-59-48(44(88)42(86)34(20-81)98-59)100-58-45(89)47(101-60(66)96)43(87)35(21-82)97-58)56(95)74-27(3)41(85)26(2)52(91)78-39(28(4)83)54(93)71-16-9-37-75-33(23-102-37)57-76-32(22-103-57)53(92)70-15-8-14-68-12-6-5-11-67-13-7-10-61/h19,22-24,26-30,34-35,39-48,58-59,67-68,72,81-83,85-89H,5-18,20-21,61-62H2,1-4H3,(H2,63,84)(H2,65,90)(H2,66,96)(H,69,73)(H,70,92)(H,71,93)(H,74,95)(H,78,91)(H,79,94)(H2,64,77,80)/t26-,27+,28+,29-,30-,34-,35+,39-,40-,41-,42+,43+,44-,45-,46-,47-,48-,58+,59-/m0/s1

HIDE SMILES / InChI
Bleomycin A6 (also known as boanmycin) was developed in China as an antineoplastic antibiotic. This drug participated in clinical trials for the treatment of Squamous Cell Lung Cancer. It was shown that besides the antitumor effect, Bleomycin A6 had the ability to alter the tumor microenvironment and could contribute toward lung cancer relapse and metastasis on long-term treatment. The development of this drug, apparently, was discontinued.

Approval Year

PubMed

PubMed

TitleDatePubMed
[Preclinical pharmacologic evaluation of bleomycin A6].
1989 Jul
[Inhibitory effect of bleomycin A6 on human colon cancer xenografts in nude mice].
1990 Oct
Bleomycin A6-loaded anionic liposomes with in situ gel as a new antitumoral drug delivery system.
2016

Sample Use Guides

Docetaxel 75mg/m2, intravenous infusion, day 1; Boanmycin 5-6 mg/m2
Route of Administration: Intravenous
Name Type Language
BLEOMYCIN A6
WHO-DD  
Common Name English
ZHENGGUANGMYCIN A6
Common Name English
PINGYANGMYCIN A6
Common Name English
N(SUP 1)-(3-((4-((3-AMINOPROPYL)AMINO)BUTYL)AMINO)PROPYL)BLEOMYCINAMIDE
Common Name English
Bleomycin A6 [WHO-DD]
Common Name English
BOANMYCIN
Common Name English
BLEOMYCINAMIDE, N(SUP 1)-(3-((4-((3-AMINOPROPYL)AMINO)BUTYL)AMINO)PROPYL)-
Common Name English
BLEOMYCINAMIDE, N1-(3-((4-((3- AMINOPROPYL)AMINO)BUTYL)AMINO)PROPYL)-
Common Name English
Code System Code Type Description
SMS_ID
300000019152
Created by admin on Sat Dec 16 02:03:24 GMT 2023 , Edited by admin on Sat Dec 16 02:03:24 GMT 2023
PRIMARY
DRUG BANK
DB12992
Created by admin on Sat Dec 16 02:03:24 GMT 2023 , Edited by admin on Sat Dec 16 02:03:24 GMT 2023
PRIMARY
CAS
37293-17-7
Created by admin on Sat Dec 16 02:03:24 GMT 2023 , Edited by admin on Sat Dec 16 02:03:24 GMT 2023
PRIMARY
PUBCHEM
9877229
Created by admin on Sat Dec 16 02:03:24 GMT 2023 , Edited by admin on Sat Dec 16 02:03:24 GMT 2023
PRIMARY
EPA CompTox
DTXSID001318678
Created by admin on Sat Dec 16 02:03:24 GMT 2023 , Edited by admin on Sat Dec 16 02:03:24 GMT 2023
PRIMARY
FDA UNII
0B19OCB220
Created by admin on Sat Dec 16 02:03:24 GMT 2023 , Edited by admin on Sat Dec 16 02:03:24 GMT 2023
PRIMARY
MESH
C052656
Created by admin on Sat Dec 16 02:03:24 GMT 2023 , Edited by admin on Sat Dec 16 02:03:24 GMT 2023
PRIMARY